F5B-45347-27150
2 vaccinations
2 coded responses
13 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 928 / CA
- Registered
- 2021-08-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-03
Dose 1 — Pfizer-BioNTech
-
2021-08-04
Registered in v-safe
- 2021-08-04
-
2021-08-06
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: Pain, RednessFree text: Dark bruise at injection siteMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-07
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: RednessFree text: Bruising at injection siteMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-08-09
- 2021-08-10
- 2021-08-17
-
2021-08-24
Dose 2 — Pfizer-BioNTech
- 2021-08-24
- 2021-09-14
- 2021-09-21
- 2021-09-28
- 2021-10-05
- 2021-11-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-03 | Pfizer-BioNTech | No |
| 2 | 2021-08-24 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Dark bruise at injection site
Systemic reaction (other): Bruising at injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site bruising | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release